Literature DB >> 17585941

Hypertonic saline: first-line therapy for cerebral edema?

Wendy C Ziai1, Thomas J K Toung, Anish Bhardwaj.   

Abstract

This article highlights the experimental and clinical data, controversies and postulated mechanisms surrounding osmotherapy with hypertonic saline (HS) solutions in the neurocritical care arena and builds on previous reviews on the subject. Special attention is focused on HS therapy on commonly encountered clinical paradigms of acute brain injury including traumatic brain injury (TBI), post-operative "retraction edema", intracranial hemorrhage (ICH), tumor-associated cerebral edema, and ischemia associated with ischemic stroke.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17585941     DOI: 10.1016/j.jns.2007.04.048

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

1.  Hypertonic/hyperoncotic solution attenuate blood-brain barrier breakdown and brain pathology in whole body hyperthermia rats.

Authors:  Youtan Liu; Jing Tang; Jionxian Ye; Lifang Zhan; Shaonong Huang; Tingting Wang; Miaoning Gu
Journal:  Int J Clin Exp Med       Date:  2011-10-19

2.  Treatment of malignant brain edema and increased intracranial pressure after stroke.

Authors:  Michael E Brogan; Edward M Manno
Journal:  Curr Treat Options Neurol       Date:  2015-01       Impact factor: 3.598

3.  Comparison of equiosmolar dose of hyperosmolar agents in reducing intracranial pressure-a randomized control study in pediatric traumatic brain injury.

Authors:  S Arun Kumar; Bhagavatula Indira Devi; Madhusudan Reddy; Dhaval Shukla
Journal:  Childs Nerv Syst       Date:  2019-03-16       Impact factor: 1.475

4.  Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities.

Authors:  Eduardo Paredes-Andrade; Craig A Solid; Sarah B Rockswold; Rick M Odland; Gaylan L Rockswold
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 5.  Osmotherapy in neurocritical care.

Authors:  Anish Bhardwaj
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

6.  The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema.

Authors:  Emil Zeynalov; Chih-Hung Chen; Stanley C Froehner; Marvin E Adams; Ole Petter Ottersen; Mahmood Amiry-Moghaddam; Anish Bhardwaj
Journal:  Crit Care Med       Date:  2008-09       Impact factor: 7.598

7.  Use of hypertonic continuous venovenous hemodiafiltration to control intracranial hypertension in an end-stage renal disease patient.

Authors:  Stephen I Rifkin; Ali R Malek; Reza Behrouz
Journal:  Int J Nephrol       Date:  2010-07-15

8.  Hematoma Enlargement Among Patients with Traumatic Brain Injury: Analysis of a Prospective Multicenter Clinical Trial.

Authors:  Adnan I Qureshi; Ahmed A Malik; Malik M Adil; Archie Defillo; Gregory T Sherr; M Fareed K Suri
Journal:  J Vasc Interv Neurol       Date:  2015-07

9.  Hypertonic saline attenuates cord swelling and edema in experimental spinal cord injury: a study utilizing magnetic resonance imaging.

Authors:  Yvette S Nout; Georgeta Mihai; C Amy Tovar; Petra Schmalbrock; Jacqueline C Bresnahan; Michael S Beattie
Journal:  Crit Care Med       Date:  2009-07       Impact factor: 7.598

Review 10.  Clinical review: Critical care management of spontaneous intracerebral hemorrhage.

Authors:  Fred Rincon; Stephan A Mayer
Journal:  Crit Care       Date:  2008-12-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.